These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 4729646
1. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma]. Beretta G, Bajetta E, Bonadonna G, Tancini G, Orefice S, Veronesi U. Tumori; 1973; 59(3):239-48. PubMed ID: 4729646 [No Abstract] [Full Text] [Related]
2. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer. Falkson G, van Eden EB, Falkson HC. Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974 [No Abstract] [Full Text] [Related]
3. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma. Van Dyk JJ, Falkson G. Med Pediatr Oncol; 1975 May; 1(2):107-11. PubMed ID: 1228411 [Abstract] [Full Text] [Related]
4. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. Carter SK, Friedman MA. Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317 [No Abstract] [Full Text] [Related]
5. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma. Ahmann DL, Hahn RG, Bisel HF. Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357 [No Abstract] [Full Text] [Related]
6. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma. Falkson G, Van der Merwe AM, Falkson HC. Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061 [No Abstract] [Full Text] [Related]
7. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer. Stolinsky DC, Bogdon DL, Solomon J, Bateman JR. Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351 [No Abstract] [Full Text] [Related]
15. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children. Finklestein JZ, Albo V, Ertel I, Karon M, Hammond D. Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686 [No Abstract] [Full Text] [Related]
16. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma. Einhorn LH, McBride CM, Luce JK, Caoili E, Gottlieb JA. Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911 [No Abstract] [Full Text] [Related]
17. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma. Ahmann DL, Hahn RG, Bisel HF. Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592 [No Abstract] [Full Text] [Related]